The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

Soon after President Trump won the presidential election in November, British drugmaker GSK brought an unusual claim to federal prosecutors in Manhattan, according to people familiar with the matter.